Skip to main content

Bicycle Therapeutics PLC

BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001761612

No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Bicycle Therapeutics PLC changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of BCYC: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders691101+33
Shares14.2M17.5K21.6M+7.37M (+51.9%)
Value$591.1M$726.0K$1.31B+$721.6M (+122.2%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held Bicycle Therapeutics PLC at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to BCYC in Q4 2021
InstitutionSharesValue% of portfolio
Ridgeback Capital Investments L.P.2,164,801$131.8M71.77%
Deep Track Capital, LP1,100,000$67.0M4.95%
RTW Investments, LP869,271$52.9M0.77%
Price T Rowe Associates Inc796,014$48.5M0.00%
Loomis Sayles & Co L P570,047$34.7M0.04%
Driehaus Capital Management LLC267,032$16.3M0.17%
BlackRock Inc.203,995$12.4M0.00%
Great Point Partners LLC200,000$12.2M2.72%
Millennium Management LLC152,732$9.30M0.01%
Handelsbanken Fonder AB80,000$4.87M0.02%
Renaissance Technologies LLC73,179$4.45M0.01%
Sio Capital Management, LLC54,000$3.29M1.00%
Voloridge Investment Management, LLC52,575$3.20M0.02%
Goldstream Capital Management Ltd48,257$2.94M0.72%
LMR Partners LLP40,000$2.44M0.03%
Harbor Capital Advisors, Inc.34,600$2.11M0.77%
TD Asset Management Inc31,586$1.92M0.00%
Ensign Peak Advisors, Inc18,260$1.11M0.00%
Vident Investment Advisory, LLC17,933$1.09M0.03%
Erste Asset Management GmbH14,000$821.5K0.01%
Jane Street Group, LLC13,386$814.0K0.00%
DekaBank Deutsche Girozentrale12,000$675.0K0.00%
Soleus Capital Management, L.P.10,250$624.0K0.08%
Squarepoint Ops LLC8,200$499.0K0.00%
Twelve Points Wealth Management LLC7,100$432.0K0.35%
Shilanski & Associates, Inc.5,156$314.0K0.13%
Trexquant Investment LP4,370$266.0K0.02%
Castleview Partners, LLC15,704$258.0K0.00%
Susquehanna Fundamental Investments, LLC4,200$256.0K0.01%
SEI Investments Co3,760$229.0K0.00%
Tower Research Capital LLC (TRC)3,727$227.0K0.00%
Claro Advisors LLC3,637$221.0K0.08%
Difesa Capital Management, LP3,500$213.0K0.15%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys3,373$205.0K0.00%
Northern Trust Corp2,905$177.0K0.00%
Simplex Trading, LLC1,557$94.0K0.00%
Signet Financial Management, LLC665$40.0K0.01%
Quantbot Technologies LP559$34.0K0.00%
High Net Worth Advisory Group LLC500$30.0K0.01%
Leonteq Securities AG270$16.4K0.00%
McDonald Partners LLC70$4.26K0.00%
Absolute Capital Management, LLC70$4.26K0.00%
Daiwa Securities Group Inc.58$4.00K0.00%
Zullo Investment Group, Inc.50$3.00K0.00%
Parallel Advisors, LLC5$00.00%

Sold out (12)

Institutions that held Bicycle Therapeutics PLC at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of BCYC in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Atlas Venture Advisors, Inc.307,696$12.8M
Ghost Tree Capital, LLC100,000$4.16M
Schonfeld Strategic Advisors LLC59,972$2.49M
Moody Aldrich Partners LLC59,053$2.46M
Acuta Capital Partners, LLC38,184$1.59M
Susquehanna International Group, LLP18,475$768.0K
Bank of New York Mellon Corp8,490$353.0K
Glenmede Trust Co NA6,436$267.0K
State of New Jersey Common Pension Fund D4,880$203.0K
KBC Group NV3,750$156.0K
Evolution Wealth Advisors, LLC120$5.00K
Deutsche Bank AG1$0

Not filed for Q4 2021 yet (1)

Institutions that held Bicycle Therapeutics PLC at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCYC in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.17,458$726.0K